检验医学 ›› 2025, Vol. 40 ›› Issue (6): 576-582.DOI: 10.3969/j.issn.1673-8640.2025.06.011

• 论著 • 上一篇    下一篇

血清miR-524-5p和miR-708-5p表达在喉癌预后评估中的价值

曲莉, 曹华琳, 张蕊, 杨喜科, 尹昕   

  1. 南阳市中心医院耳鼻咽喉科,河南 南阳 473000
  • 收稿日期:2024-05-16 修回日期:2025-02-07 出版日期:2025-06-30 发布日期:2025-07-01
  • 作者简介:曲 莉,女,1980年生,硕士,副主任医师,主要从事耳鼻咽喉疾病相关研究。

Roles of serum miR-524-5p and miR-708-5p expression levels in prognostic assessment of laryngeal cancer

QU Li, CAO Hualin, ZHANG Rui, YANG Xike, YIN Xin   

  1. Department of Otolaryngology,Nanyang Central Hospital,Nanyang 473000,Henan,China
  • Received:2024-05-16 Revised:2025-02-07 Online:2025-06-30 Published:2025-07-01

摘要:

目的 探讨血清miR-524-5p、miR-708-5p水平与喉癌患者临床病理特征、预后的关系。方法 选取2018年1月—2021年1月南阳市中心医院喉癌患者93例(喉癌组)和健康体检者93名(正常对照组)。收集所有研究对象的临床资料,并检测血清miR-524-5p、miR-708-5p相对表达量。对所有患者随访3年。采用Pearson相关分析评估miR-524-5p与miR-708-5p的相关性。采用受试者工作特征(ROC)曲线评价血清miR-524-5p和miR-708-5p诊断喉癌的效能。采用Kaplan-Meier生存曲线分析不同miR-524-5p和miR-708-5p表达喉癌患者的生存情况。采用Cox回归分析评估喉癌患者死亡的影响因素。结果 喉癌组血清miR-524-5p、miR-708-5p相对表达量均显著低于正常对照组(P<0.001)。喉癌患者血清miR-524-5p与miR-708-5p表达呈正相关(r=0.714,P<0.05)。血清miR-524-5p和miR-708-5p诊断喉癌的曲线下面积(AUC)分别为0.801、0.753,最佳临界值分别为0.788、0.813。有无淋巴转移和不同肿瘤直径、TNM分期、肿瘤分化程度的喉癌患者血清miR-524-5p、miR-708-5p相对表达量差异均有统计学意义(P<0.05),不同性别、年龄、肿瘤部位、肿瘤浸润深度和病理类型的喉癌患者血清miR-524-5p、miR-708-5p相对表达量差异均无统计学意义(P>0.05)。根据ROC曲线得出的miR-524-5p和miR-708-5p的最佳临界值将所有患者分别分为高表达组和低表达组。miR-524-5p高表达组和miR-708-5p高表达组生存率均高于各自的低表达组(P<0.05)。有淋巴转移、肿瘤直径>3.0 cm、低分化、TNM分期为Ⅲ~Ⅳ期、miR-524-5p低表达、miR-708-5p低表达为喉癌患者死亡的危险因素(P<0.05)。结论 喉癌患者血清miR-524-5p、miR-708-5p相对表达量降低,且与其临床病理特征和预后密切相关,或可作为喉癌预后评估的生物标志物。

关键词: 微小RNA-524-5p, 微小RNA-708-5p, 喉癌, 预后

Abstract:

Objective To investigate the relationship between the levels of serum miR-524-5p and miR-708-5p and the clinicopathological characteristics and prognosis of patients with laryngeal cancer. Methods A total of 93 patients with laryngeal cancer(laryngeal cancer group) and 93 healthy subjects(healthy control group) in Nanyang Central Hospital from January 2018 to January 2021 were enrolled. The clinical data of all patients were collected,and the relative expression levels of miR-524-5p and miR-708-5p were determined. All the patients were followed up for 3 years. Pearson correlation analysis was used to analyze the correlation between miR-524-5p and miR-708-5p. The efficacy of serum miR-524-5p and miR-708-5p in the diagnosis of laryngeal cancer was evaluated by receiver operating characteristic(ROC) curve. The survival conditions of laryngeal cancer patients with different expressions of miR-524-5p and miR-708-5p were analyzed using Kaplan-Meier survival curve. Cox regression analysis was used to evaluate the influencing factors of death in patients with laryngeal cancer. Results The relative expression levels of serum miR-524-5p and miR-708-5p in laryngeal cancer group were lower than those in healthy control group(P<0.001). The expression of serum miR-524-5p in patients with laryngeal cancer was positively correlated with that of miR-708-5p(r=0.714,P<0.05). The areas under curves(AUC) of serum miR-524-5p and miR-708-5p in the diagnosis of laryngeal cancer were 0.801 and 0.753,respectively,and the optimal cut-off values were 0.788 and 0.813,respectively. There was statistical significance in the relative expression levels of serum miR-524-5p and miR-708-5p among laryngeal cancer patients with lymphatic metastasis,different tumor diameters,TNM stages and degrees of differentiation(P<0.05). There was no statistical significance in the relative expression levels of serum miR-524-5p and miR-708-5p among laryngeal cancer patients of different genders,ages,tumor locations,tumor invasion depths and pathological types(P>0.05). The optimal cut-off values of miR-524-5p and miR-708-5p were used to classify the subjects into high-expression group and low-expression group. The survival rates of both miR-524-5p high-expression group and miR-708-5p high-expression group were higher than those of their low-expression groups(P<0.05). Lymphatic metastasis,tumor diameter>3.0 cm,low differentiation,TNM stage Ⅲ-Ⅳ,low expression of miR-524-5p and low expression of miR-708-5p were risk factors for death in patients with laryngeal cancer(P<0.05). Conclusions The relative expression levels of serum miR-524-5p and miR-708-5p in laryngeal cancer patients are decreased,and both of them are related to clinicopathological characteristics and prognosis,which may be used as markers for prognostic assessment of laryngeal cancer.

Key words: MicroRNA-524-5p, MicroRNA-708-5p, Laryngeal cancer, Prognosis

中图分类号: